RenovoRx Inc

RenovoRx Inc (RNXT) Price Prediction & Forecast

$1.135

-0.052 (-4.62%)At close

Price Predictions

1-Day Price Prediction
-0.91%
1-Week Prediction
-4.05%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

RNXT Prediction & Forecast by Similar Chart Analysis

Alphio's RNXT stock price prediction model matches the current RenovoRx Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (-0.91%). The 1-week path is $1.09 (-4.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy RenovoRx Inc Stock?

RenovoRx Inc is a good buy right now due to its recent strong revenue growth and positive clinical trial results. The stock closed at $1.26, which is significantly below the analyst price target of $14.50, indicating a potential upside of over 1,000%. Additionally, the company reported a record revenue of $909,000 for Q2 2026, reflecting a 61% sequential increase and a 115% year-over-year rise. The main risk is the negative earnings per share (EPS) of -0.06 reported for Q2 2026, which indicates ongoing losses but is improving compared to previous quarters.

RNXT stock price ended at $1.14 on Friday, after losing -4.62%

RenovoRx Inc (RNXT) last closed at $1.135, losing -4.62%. These facts feed the 1-day and 1-week RNXT price prediction above.

Forecast Drivers

RenovoRx Inc (RNXT) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches RNXT, ranked by similarity.

Seasonality analysis for RNXT

Historically the probability of a positive November return for RNXT is 11.36%. June offers the highest probability of a positive month at 53.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading